Unambiguous transcriptome-wide identification of microRNA:mRNA interactions through enhanced chimeric read amplification
Award amount
$349,750Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Eclipse Bioinnovations, Inc.
- Proposal award date
- 2019-09-17
- Contract end date
- 2020-08-31
- UEI
- NKBUXMSL35L8
- Solicitation number
- PA18-574
- Topic code
- NHGRI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening
- eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening
- Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide
- A robust kit, standards, and software for identifying RNA binding protein targets
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform to support clinical variant interpretation through probabilistic assessment of functional evidence
- Innovations to expand and accelerate the commercial impact of DNA modifications
- High-throughput Direct Sequencing and Quantitative Mapping of RNA Modifications using Mass Spectrometry.
- Super-resolution single-molecule sequencing by observing the dynamic hybridization of a repertoire of oligonucleotides to DNA targets
- Exhaustive de novo sequencing of every RNA in a sample by a layer-by-layer mass spectrometry ladder intensity approach.
Research funding history
5 SBIR/STTR records share this UEI (2017–2025). Reported award amounts total $5,376,315. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services